Warning: The NCBI web site requires JavaScript to function. more...
HIV-1 latency in actively dividing human T cell lines.
Jeeninga RE, Westerhout EM, van Gerven ML, Berkhout B.
Retrovirology. 2008 Apr 25;5:37.
Related citations
Latency: the hidden HIV-1 challenge.
Marcello A.
Retrovirology. 2006 Jan 16;3:7. Review.
A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
Macías D, Oya R, Saniger L, Martín F, Luque F.
Hum Gene Ther. 2009 Nov;20(11):1259-68.
Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo.
Hermankova M, Siliciano JD, Zhou Y, Monie D, Chadwick K, Margolick JB, Quinn TC, Siliciano RF.
J Virol. 2003 Jul;77(13):7383-92.
Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
Li XD, Moore B, Cloyd MW.
Virology. 1996 Nov 1;225(1):196-212.
Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells.
Lassen KG, Ramyar KX, Bailey JR, Zhou Y, Siliciano RF.
PLoS Pathog. 2006 Jul;2(7):e68.
Analysis of human immunodeficiency virus type 1 transcriptional elongation in resting CD4+ T cells in vivo.
Lassen KG, Bailey JR, Siliciano RF.
J Virol. 2004 Sep;78(17):9105-14.
Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency.
Krishnan V, Zeichner SL.
J Virol. 2004 Sep;78(17):9458-73.
Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs.
Coiras M, López-Huertas MR, Pérez-Olmeda M, Alcamí J.
Nat Rev Microbiol. 2009 Nov;7(11):798-812. Review.
Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli.
Swiggard WJ, Baytop C, Yu JJ, Dai J, Li C, Schretzenmair R, Theodosopoulos T, O'Doherty U.
J Virol. 2005 Nov;79(22):14179-88.
Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses.
Chen BK, Saksela K, Andino R, Baltimore D.
J Virol. 1994 Feb;68(2):654-60.
Mechanisms of HIV latency: an emerging picture of complexity.
Margolis DM.
Curr HIV/AIDS Rep. 2010 Feb;7(1):37-43. Review.
Regulation of HIV-1 latency by T-cell activation.
Williams SA, Greene WC.
Cytokine. 2007 Jul;39(1):63-74. Epub 2007 Jul 20. Review.
The multifactorial nature of HIV-1 latency.
Lassen K, Han Y, Zhou Y, Siliciano J, Siliciano RF.
Trends Mol Med. 2004 Nov;10(11):525-31. Review.
Sustained induction of NF-kappa B is required for efficient expression of latent human immunodeficiency virus type 1.
Williams SA, Kwon H, Chen LF, Greene WC.
J Virol. 2007 Jun;81(11):6043-56. Epub 2007 Mar 21.
HIV type-1 latency: targeted induction of proviral reservoirs.
Graci JD, Colacino JM, Peltz SW, Dougherty JP, Gu Z.
Antivir Chem Chemother. 2009;19(5):177-87. Review.
Regulation of human immunodeficiency virus-1 latency and its reactivation.
Verdin E.
Bull Mem Acad R Med Belg. 2008;163(6):355-64; discussion 364-5.
Experimental approaches to the study of HIV-1 latency.
Han Y, Wind-Rotolo M, Yang HC, Siliciano JD, Siliciano RF.
Nat Rev Microbiol. 2007 Feb;5(2):95-106. Review.
Transcriptional effects of superinfection in HIV chronically infected T cells: studies in dually infected clones.
Kim JH, McLinden RJ, Mosca JD, Burke DS, Boswell RN, Birx DL, Redfield RR.
J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 1;12(4):329-42.
Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.
Colin L, Van Lint C.
Retrovirology. 2009 Dec 4;6:111. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on